Business
RavenQuest Announces Non-Brokered Private Placement
RavenQuest Announces Non-Brokered Private Placement.
About this update from Ravenquest Biomed Inc
[{"type":"text","content":"\nNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS\n VANCOUVER, British Columbia, March 07, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”) announces that it will conduct a non-brokered private placement of up to 5,000,000 units (each, a “Unit”) at a price of CDN $0.60 per Unit  to raise an aggregate CDN $3,000,000 (the “Financing”). Each Unit will consist of one common share in the equity of the Company and one-half-of-one share purchase warrant (the “Warrant”).  Each Warrant will entitle the holder to purchase one additional common share of the Company at a price of CDN $0.80 per share for a period of two (2) years from the closing of the Financing, subject to accelerated expiry in the event the closing price of the Company’s shares is greater than CDN$1.60 for ten consecutive trading days. The proceeds of the Financing will be used for general corporate purposes.  The Company may pay a finder’s fee to qualified finders in respect to the Financing.  Securities issued as a result of the Financing will be subject to a statutory hold period. About RavenQuest BioMed Inc. RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.  RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with Montreal’s McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.  The Company focuses on partnerships with Indigenous communities. On Behalf of the Board of Directors ofRAVENQUEST BIOMED INC. \"George Robinson\"Chief Executive Officer For further information, please contact:   Mathieu McDonald, Corporate Communications1-877-282-1586    Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) ac...